@FierceBiotech: Indian supreme court: Unregulated trials causing 'havoc'. More | Follow @FierceBiotech
@JohnCFierce: As Big Pharma falters, Big Biotech helps fill a $100B "gap." Editor's Corner | Follow @JohnCFierce
@RyanMFierce: Boehringer doesn't want $LLY's basal insulin analog anymore, amends big diabetes pact. News | Follow @RyanMFierce
> Roche's ($RHHBY) chairman shot down chances of his company mounting another effort to acquire Illumina ($ILMN). Item
> Peregrine Pharmaceuticals ($PPHM) shares soared more than 60% on Monday on the back of news that its review of data from a midstage study of its candidate bavituximab in patients with non-small cell lung cancer has encouraged the company to advance the drug into Phase III development. Item
> Merck ($MRK) says that the FDA has accepted its resubmitted NDA for its contender called sugammadex for reversing neuromuscular blockade. Item
> Vertex ($VRTX) updated on key programs in hepatitis C and cystic fibrosis and plans for 2013. Release
@FierceMedDev: Johnson & Johnson's first vaginal mesh trial revs up this week. More | | Follow @FierceMedDev
@MarkHFierce: Illumina is grabbing Verinata Health for $350M-plus. The buy gets it into fetal Dx business. Story | Follow @MarkHFierce
@DamianFierce: Unregulated clinical trials are wreaking "havoc" in India, the supreme court says. News | Follow @DamianFierce
> SeraCare refocuses energies on in vitro Dx work. Item
> EndoChoice grabs $45M to back merger with Israeli GI startup. Story
Pharma News
@FiercePharma: Eli Lilly's 2013 profits forecast surpasses analyst predictions. What gives? More | Follow @FiercePharma
@AlisonBFierce: What's the buzz? Big Pharma may be on the verge of a buying spree. News | Follow @AlisonBFierce
> Roche chairman pooh-poohs another Illumina bid. Report
> Valeant chief shoots for $10B in sales--and then $20B. Story
Biotech IT News
> Quants collaborate on forecasting value of genomics in medicine. Story
> Is FDA keeping social media from taking flight in pharma? Editor's Corner
> Abbott spinoff AbbVie starts social media effort from scratch. Article
> Agilent unit picks up lab software rights to fuel cancer diagnostics biz. News
CRO News
> WCCT partners with U.S.'s largest trial registry on patient adherence. Article
> Questcor snags CMO BioVectra for $50.7M. News
> Cellular Dynamics signs on with AstraZeneca for drug discovery. Story
> Indian Supreme Court: Unregulated trials causing 'havoc'. Report
> Clinical Network Services buys CRO Beltas. Item
And Finally… Health insurers, not as much the FDA, give biotech chiefs the jitters. Column